Annual Drug Patent Expirations for TRUVADA
Truvada is a drug marketed by Gilead and is included in one NDA. It is available from seven suppliers. There are six patents protecting this drug and two Paragraph IV challenges.
Drug patent litigation for TRUVADA.
This drug has fifty-nine patent family members in twenty-nine countries.
The generic ingredient in TRUVADA is emtricitabine; tenofovir disoproxil fumarate. Seven suppliers are listed for this compound. Additional details are available on the emtricitabine; tenofovir disoproxil fumarate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
